Comparison of biochemical markers of bone resorption in patients with metabolic and malignant bone diseases

Annals of Clinical Biochemistry

Volumn 33, Issue 5, 1996, Pages 421-427

  Withold, W ^a   Friedrich, W ^a   Reinauer, H ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bone metastases; Pyridinium cross links; Renal transplantation; Telopeptides

Indexed keywords

3 HYDROXYPYRIDINE DERIVATIVE; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; PARATHYROID HORMONE; PYRIDINIUM DERIVATIVE; PYRIDINOLINE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE CANCER; BONE DISEASE; BONE METASTASIS; BONE SCINTISCANNING; CLINICAL CHEMISTRY; COLLAGEN METABOLISM; CONTROLLED STUDY; CROSS LINKING; FEMALE; HORMONE BLOOD LEVEL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; OSTEOLYSIS; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0029809248     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300504     Document Type: Article

References (16)

1. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of hone resorption in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994; 79: 1693-700
2. Hanson DA, Weis MAE, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Min Res 1992; 7: 1251-8
3. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994; 40: 2022-5
4. Withold W, Degenhardt S, Castelli D, Heins M, Grabensee B. Monitoring of osteoblast activity by an immunoradiometric assay for determination of bone alkaline phosphatase mass concentration in patients receiving renal transplants. Clin Chim Acta 1994; 225: 137-46
5. Withold W, Degenhardt S, Heins M, Grahensee B, Reinauer H, Monitoring of hone resorption after renal transplantation by measuring the urinary excretion of pyridinium cross-links. Eur J Clin Chem Clin Biochem 1995; 33: 15-21
6. Pecherstorfer M, Zimmer-Roth I, Schilling T, Woitge HW, Schmidt H, Baumgartner G, et al. The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease. J Clin Endocrinol Metab 1995; 80: 97-103
7. Helger R, Rindfrey H, Hilgenfeldt J. Eine Methode zur direkten Bestimmung des Creatinins im Serum und Urin ohne Enteiweiβung nach einer modifizierten Jaffé-Methode. Z Klin Chem Klin Biochem 1974; 12: 344-9
8. Sachs L. Statistische Methoden: Planung und Auswertung, 6th edn. Berlin, Heidelberg. New York. London, Paris, Tokyo: Springer. 1988
9. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, et al. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int 1994; 54: 26-9
10. Bollen AM, Eyre DR. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone 1994; 15: 31-4
11. Gertz BJ, Shao P, Hanson DA, Quan H, Harris ST, Genant HK, et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 1994; 9: 135-42
12. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PD, Deftos LJ, et al. The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 1994; 79: 366-71
13. TM): Correlation to hydroxyproline. Scand J Clin Lab Invest 1995; 55: 187-92
14. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995; 80: 864-8
15. Garnero P, Gineyts E, Riou JP, Delmas PD. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 1994; 79: 780-5
16. Miyamoto KK, McSherry SA, Robins SP, Besterman JM, Mohler JL. Collagen cross-links metabolites in urine as markers of bone metastases in prostatic cancer. J Urol 1994; 151: 909-13